Lupin Healthcare is a subsidiary of the global pharmaceutical company Lupin Limited, who’s heritage lies in generic medicines. Today’s portfolio consists of high quality generics with a focus on anti-retroviral and oral contraceptives. January 2019 sees the launch of Lupin’s first specialist medicine in the area of neurology. The future pipeline will have a focus in specialist medicines and complex generics.
As part of the global Lupin organisation, Lupin Healthcare UK establishes and maintains high standards of quality for its products manufactured both at Lupin sites and at contract manufacturing sites through well-defined quality assurance systems to support product identity, purity, safety and efficacy.
Lupin Healthcare (UK) Limited holds a Manufacturers/Importer Authorisation (MIA 35507) and Wholesale Dealers Authorisation (WDA(H) 35507) issued by the Medicines and Healthcare products Regulatory Agency (MHRA).
Lupin was founded on the auspicious “Guddi padwa’ Day in 1968 by Dr. Desh Bandhu Gupta - a visionary with a compelling mission to create a better world for people. DBG as he was fondly called, started the company with a dream - a dream to fight life-threatening, infectious diseases with affordable and high-quality drugs of the highest social priority. With his vision, inimitable commitment and passion, Dr. Gupta steered the organization to become one of the fastest-growing Generic pharmaceutical companies around the world.
The name ‘Lupin’ was inspired by the flower Lupin which is known to nourish the soil it grows in.
The Lupin flower is also known to be tolerant of the infertile soils and capable of pioneering change in barren and poor climates. This inspiration is at the core of the company’s ethos as it relentlessly strives to build medical solutions to meet the unmet needs of the society not just for a few but for the many across the globe.
At Lupin, Corporate Governance has been an integral part of the way we conduct business. Good governance practices which are pre-requisite for attaining sustainable growth are embedded in our culture.
Corporate Governance is about doing the ‘right things’ in the ‘right manner’ at the ‘right time’ and Lupin remains committed to set the highest governance standards in form letter and spirit.
The Directors of the Company are well-known experts in their fields with a wide range of skills and expertise.
The Board has a balanced combination of executive, non-executive and independent directors which includes two women directors.
The Company promotes a culture of open deliberations, transparency and impartiality and does not tolerate corrupt and immoral practices. The Company adheres to the well-accepted norms of ethical, moral and legal conduct in its business operations.
As a testament of its robust corporate governance practices and ethical conduct of business, the Company instituted P.L.E.D.G.E. (Preparing Lupin Employees to Demonstrate Governance and Ethical Conduct), which enforces a common code of ethics, empowers employees to report unethical practices, ensures swift redressal and institutes specific mechanisms to deal with workplace harassment.
Lupin is in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 on Corporate Governance.